Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

OBJECTIVES: To assess the effect of golimumab, with or without methotrexate (MTX), on serum lipids and inflammatory markers of cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA) in two phase 3, randomised, placebo-controlled trials (GO-BEFORE and GO-FORWARD). METHODS: Patients i...

Descripción completa

Detalles Bibliográficos
Autores principales: Kirkham, Bruce W, Wasko, Mary Chester, Hsia, Elizabeth C, Fleischmann, Roy M, Genovese, Mark C, Matteson, Eric L, Liu, Hongjuan, Rahman, Mahboob U
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888596/
https://www.ncbi.nlm.nih.gov/pubmed/23300117
http://dx.doi.org/10.1136/annrheumdis-2012-202089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888596/
https://www.ncbi.nlm.nih.gov/pubmed/23300117
http://dx.doi.org/10.1136/annrheumdis-2012-202089

Ejemplares similares